Single Point Partners LLC Has $224,000 Holdings in Danaher Co. (NYSE:DHR)

Single Point Partners LLC boosted its holdings in Danaher Co. (NYSE:DHRFree Report) by 15.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 967 shares of the conglomerate’s stock after acquiring an additional 128 shares during the period. Single Point Partners LLC’s holdings in Danaher were worth $224,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in DHR. Moneta Group Investment Advisors LLC raised its stake in Danaher by 96,490.5% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 23,287,013 shares of the conglomerate’s stock valued at $6,180,839,000 after acquiring an additional 23,262,904 shares during the period. Norges Bank bought a new position in Danaher during the 4th quarter worth $2,057,164,000. Wellington Management Group LLP increased its position in Danaher by 18.6% during the 3rd quarter. Wellington Management Group LLP now owns 24,930,281 shares of the conglomerate’s stock worth $6,185,203,000 after buying an additional 3,905,449 shares during the period. JPMorgan Chase & Co. increased its position in Danaher by 66.6% during the 2nd quarter. JPMorgan Chase & Co. now owns 5,997,282 shares of the conglomerate’s stock worth $1,439,348,000 after buying an additional 2,398,426 shares during the period. Finally, Capital International Investors increased its position in Danaher by 20.4% during the 2nd quarter. Capital International Investors now owns 14,029,348 shares of the conglomerate’s stock worth $3,366,677,000 after buying an additional 2,377,625 shares during the period. Institutional investors own 76.71% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of several recent research reports. TheStreet upgraded Danaher from a “c+” rating to a “b-” rating in a research report on Friday, December 8th. Raymond James increased their price objective on Danaher from $240.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Citigroup increased their price objective on Danaher from $255.00 to $280.00 and gave the stock a “buy” rating in a research report on Wednesday, January 31st. JPMorgan Chase & Co. raised their price target on Danaher from $250.00 to $270.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 20th. Finally, Wolfe Research initiated coverage on Danaher in a research report on Wednesday, December 13th. They issued a “peer perform” rating on the stock. Seven research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $266.00.

Read Our Latest Analysis on Danaher

Danaher Price Performance

NYSE:DHR traded down $2.06 during trading hours on Wednesday, hitting $251.68. The company’s stock had a trading volume of 1,472,721 shares, compared to its average volume of 2,791,814. The stock has a fifty day simple moving average of $244.24 and a 200-day simple moving average of $230.61. The company has a market capitalization of $186.17 billion, a P/E ratio of 39.39, a PEG ratio of 3.82 and a beta of 0.84. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.68 and a quick ratio of 1.37. Danaher Co. has a twelve month low of $182.09 and a twelve month high of $259.00.

Danaher (NYSE:DHRGet Free Report) last announced its quarterly earnings results on Tuesday, January 30th. The conglomerate reported $2.09 EPS for the quarter, beating analysts’ consensus estimates of $1.91 by $0.18. Danaher had a return on equity of 12.25% and a net margin of 17.26%. The firm had revenue of $6.41 billion for the quarter, compared to analyst estimates of $6.10 billion. During the same period last year, the firm posted $2.87 earnings per share. The business’s revenue for the quarter was down 10.2% on a year-over-year basis. On average, analysts anticipate that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Thursday, March 28th will be paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.43%. This is a positive change from Danaher’s previous quarterly dividend of $0.24. The ex-dividend date is Wednesday, March 27th. Danaher’s dividend payout ratio (DPR) is presently 15.02%.

Insider Activity

In related news, SVP Daniel Raskas sold 23,757 shares of Danaher stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $252.00, for a total value of $5,986,764.00. Following the transaction, the senior vice president now directly owns 38,102 shares of the company’s stock, valued at $9,601,704. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, SVP Daniel Raskas sold 23,757 shares of Danaher stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $252.00, for a total value of $5,986,764.00. Following the transaction, the senior vice president now directly owns 38,102 shares of the company’s stock, valued at $9,601,704. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Walter G. Lohr sold 3,289 shares of Danaher stock in a transaction that occurred on Thursday, February 15th. The stock was sold at an average price of $251.15, for a total value of $826,032.35. Following the completion of the transaction, the director now directly owns 14,129 shares in the company, valued at $3,548,498.35. The disclosure for this sale can be found here. Over the last three months, insiders have sold 32,957 shares of company stock valued at $8,265,802. 11.10% of the stock is currently owned by corporate insiders.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.